Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
Genomic analysis could contribute to a better understanding of the biological determinants of the evolution of multiple myeloma (MM) precursor disease and an improved definition of high-risk patients. To assess the feasibility and value of next-generation sequencing approaches in an asymptomatic set...
Main Authors: | Martina Manzoni, Valentina Marchica, Paola Storti, Bachisio Ziccheddu, Gabriella Sammarelli, Giannalisa Todaro, Francesca Pelizzoni, Simone Salerio, Laura Notarfranchi, Alessandra Pompa, Luca Baldini, Niccolò Bolli, Antonino Neri, Nicola Giuliani, Marta Lionetti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/5/1332 |
Similar Items
-
Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
by: Marta Lionetti, et al.
Published: (2021-07-01) -
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients
by: Federica Costa, et al.
Published: (2021-01-01) -
What Is New in the Treatment of Smoldering Multiple Myeloma?
by: Niccolo’ Bolli, et al.
Published: (2021-01-01) -
Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
by: Niccolo Bolli, et al.
Published: (2020-02-01) -
Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets
by: Jessica Burroughs Garcìa, et al.
Published: (2021-06-01)